Table 1 Clinical and laboratory characteristics.
Clinical characteristics Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Date of admission Jan. 3 Jan. 13 Jan. 27 Jan. 22 Jan. 20
Sex Male Male Female Female Female
Age (years) 30 42 32 27 31
Epidemiological history Yes Yes Yes Yes Yes
SARS-CoV-2 negative to positive (days) 4 8 17 15 9
Complications None None None None None
Signs and symptoms
Fever on admission Yes Yes Yes No Yes
Cough No Yes No No No
Dyspnoea No No No No No
Sore throat No No Yes No No
Fatigue Yes Yes Yes Yes Yes
Laboratory characteristics
White blood cell count (× 109 cells per L) 5.9 7.1 4.4 6.5 4.5
Neutrophil count (× 109 cells per L) 3.5 4.5 1.8 4.1 2.6
Lymphocyte count (× 109 cells per L) 1.7 1.3 1.7 1.7 1.4
Monocyte count (× 109 cells per L) 0.63 1.24 0.75 0.58 0.4
Eosinophil count (× 109 cells per L) 0.13 0.05 0.02 0.09 0
Basophile count (× 109 cells per L) 0.02 0.04 0.03 0.02 0.02
C-reactive protein (mg/L) 18.7 23.7 NA <0.50 NA
Elevated ALT (>45 U/L) or AST (>35 U/L) No No No No No
ALT (U/L) 40 16 11 9 10
AST(U/L) 32 19 20 13 22
Confirmatory test (SARS-CoV-2 PCR) Yes Yes Yes Yes Yes
CT evidence of pneumonia
Typical signs of viral infection Yes Yes Yes Yes Yes
Treatment
Antiviral therapy Yes Yes Yes Yes Yes
Antibiotic therapy Yes Yes Yes Yes Yes
Use of corticosteroid Yes Yes No No Yes
NA=not applicable. ALT=alanine transaminase. AST=aspartate transaminase.